What AI says about MagnaPulse

MagnaPulse produces pulsed electromagnetic field (PEMF) therapy systems designed to address autoimmune conditions such as ankylosing spondylitis. The company’s approach is based on a model suggesting PEMF increases cell membrane potential to reduce Tumor Necrosis Factor-mediated immune responses.

AI named MagnaPulse in December 2025.

Markets